Management

Management of common clinical problems experienced by survivors of cancer

  • 1.
    • Bluethmann SM
    • Mariotto AB
    • Rowland JH

    Anticipating the “silver tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States.

    Cancer Epidemiol Biomarkers Prev. 2016; 25: 1029-1036

  • 2.
    • Siegel RL
    • Miller KD
    • Fuchs HE
    • Jemal A

    Cancer statistics, 2021.

    CA Cancer J Clin. 2021; 71: 7-33

  • 3.
    • International Agency for Research on Cancer

    Estimated number of new cases in 2020, worldwide, both sexes, all ages (excl. NMSC).

  • 4.Hewitt M Greenfield S Stovall E From cancer patient to cancer survivor: lost in transition. The National Academies Press,
    Washington DC2006
  • 5.
    • Harrison JD
    • Young JM
    • Price MA
    • Butow PN
    • Solomon MJ

    What are the unmet supportive care needs of people with cancer? A systematic review.

    Support Care Cancer. 2009; 17: 1117-1128

  • 6.
    • Harrington CB
    • Hansen JA
    • Moskowitz M
    • Todd BL
    • Feuerstein M

    It’s not over when it’s over: long-term symptoms in cancer survivors—a systematic review.

    Int J Psychiatry Med. 2010; 40: 163-181

  • 7.
    • Lisy K
    • Langdon L
    • Piper A
    • Jefford M

    Identifying the most prevalent unmet needs of cancer survivors in Australia: a systematic review.

    Asia Pac J Clin Oncol. 2019; 15: e68-e78

  • 8.
    • Jefford M
    • Howell D
    • Li Q
    • et al.

    Improved models of care for cancer survivors.

    Lancet. 2022; 399: 1551-1560

  • 9.
    • Tonorezos ES
    • Cohn RJ
    • Glaser AW
    • et al.

    Long-term care for people treated for cancer during childhood and adolescence.

    Lancet. 2022; 399: 1561-1572

  • 10.
    • Herrmann J
    • Lerman A
    • Sandhu NP
    • Villarraga HR
    • Mulvagh SL
    • Kohli M

    Evaluation and management of patients with heart disease and cancer: cardio-oncology.

    Mayo Clin Proc. 2014; 89: 1287-1306

  • 11.
    • van Nimwegen FA
    • Schaapveld M
    • Janus CP
    • et al.

    Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.

    JAMA Intern Med. 2015; 175: 1007-1017

  • 12.
    • Curigliano G
    • Lenihan D
    • Fradley M
    • et al.

    Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.

    Ann Oncol. 2020; 31: 171-190

  • 13.
    • Armenian SH
    • Lacchetti C
    • Barac A
    • et al.

    Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.

    J Clin Oncol. 2017; 35: 893-911

  • 14.
    • de Haas EC
    • Oosting SF
    • Lefrandt JD
    • Wolffenbuttel BHR
    • Sleijfer DT
    • Gietema JA

    The metabolic syndrome in cancer survivors.

    Lancet Oncol. 2010; 11: 193-203

  • 15.

    Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis.

    BMC Med. 2012; 10: 138

  • 16.
    • DiSipio T
    • Rye S
    • Newman B
    • Hayes S

    Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.

    Lancet Oncol. 2013; 14: 500-515

  • 17.
    • Warren AG
    • Brorson H
    • Borud LJ
    • Slavin SA

    Lymphedema: a comprehensive review.

    Ann Plast Surg. 2007; 59: 464-472

  • 18.
    • Oremus M
    • Dayes I
    • Walker K
    • Raina P

    Systematic review: conservative treatments for secondary lymphedema.

    BMC Cancer. 2012; 12: 6

  • 19.
    • van den Beuken-van Everdingen MH
    • Hochstenbach LM
    • Joosten EA
    • Tjan-Heijnen VC
    • Janssen DJ

    Update on prevalence of pain in patients with cancer: systematic review and meta-analysis.

    J Pain Symptom Manage. 2016; 51: 1070-1090.e9

  • 20.
    • Mishra SI
    • Scherer RW
    • Snyder C
    • Geigle PM
    • Berlanstein DR
    • Topaloglu O

    Exercise interventions on health-related quality of life for people with cancer during active treatment.

    Cochrane Database Syst Rev. 2012; CD008465

  • 21.
    • Paley CA
    • Johnson MI
    • Tashani OA
    • Bagnall AM

    Acupuncture for cancer pain in adults.

    Cochrane Database Syst Rev. 2015; 2015CD007753

  • 22.
    • Sheinfeld Gorin S
    • Krebs P
    • Badr H
    • et al.

    Meta-analysis of psychosocial interventions to reduce pain in patients with cancer.

    J Clin Oncol. 2012; 30: 539-547

  • 23.
    • Wiffen PJ
    • Derry S
    • Moore RA
    • et al.

    Oral paracetamol (acetaminophen) for cancer pain.

    Cochrane Database Syst Rev. 2017; 7CD012637

  • 24.
    • Derry S
    • Wiffen PJ
    • Moore RA
    • et al.

    Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults.

    Cochrane Database Syst Rev. 2017; 7CD012638

  • 25.
    • Kane CM
    • Mulvey MR
    • Wright S
    • Craigs C
    • Wright JM
    • Bennett MI

    Opioids combined with antidepressants or antiepileptic drugs for cancer pain: systematic review and meta-analysis.

    Palliat Med. 2018; 32: 276-286

  • 26.
    • Koyyalagunta D
    • Bruera E
    • Solanki DR
    • et al.

    A systematic review of randomized trials on the effectiveness of opioids for cancer pain.

    Pain Physician. 2012; 15: ES39-ES58

  • 27.
    • Whiting PF
    • Wolff RF
    • Deshpande S
    • et al.

    Cannabinoids for medical use: a systematic review and meta-analysis.

    JAMA. 2015; 313: 2456-2473

  • 28.
    • Paice JA
    • Portenoy R
    • Lacchetti C
    • et al.

    Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.

    J Clin Oncol. 2016; 34: 3325-3345

  • 29.
    • Seretny M
    • Currie GL
    • Sena ES
    • et al.

    Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.

    Pain. 2014; 155: 2461-2470

  • 30.
    • Smith EML
    • Pang H
    • Cirrincione C
    • et al.

    Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

    JAMA. 2013; 309: 1359-1367

  • 31.
    • Loprinzi CL
    • Lacchetti C
    • Bleeker J
    • et al.

    Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update.

    J Clin Oncol. 2020; 38: 3325-3348

  • 32.
    • Shapiro CL
    • Van Poznak C
    • Lacchetti C
    • et al.

    Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO clinical practice guideline.

    J Clin Oncol. 2019; 37: 2916-2946

  • 33.
    • Thompson JA
    • Schneider BJ
    • Brahmer J
    • et al.

    NCCN Guidelines insights: management of immunotherapy-related toxicities, version 1.2020.

    J Natl Compr Canc Netw. 2020; 18: 230-241

  • 34.
    • Michot JM
    • Bigenwald C
    • Champiat S
    • et al.

    Immune-related adverse events with immune checkpoint blockade: a comprehensive review.

    Eur J Cancer. 2016; 54: 139-148

  • 35.
    • Haanen JBAG
    • Carbonnel F
    • Robert C
    • et al.

    Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

    Ann Oncol. 2017; 28: iv119-iv142

  • 36.
    • Mitchell AJ
    • Ferguson DW
    • Gill J
    • Paul J
    • Symonds P

    Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis.

    Lancet Oncol. 2013; 14: 721-732

  • 37.
    • Walker J
    • Holm Hansen C
    • Martin P
    • et al.

    Prevalence of depression in adults with cancer: a systematic review.

    Ann Oncol. 2013; 24: 895-900

  • 38.
    • Brandenbarg D
    • Maass SWMC
    • Geerse OP
    • et al.

    A systematic review on the prevalence of symptoms of depression, anxiety and distress in long-term cancer survivors: implications for primary care.

    Eur J Cancer Care (Engl). 2019; 28e13086

  • 39.
    • Oberoi S
    • Yang J
    • Woodgate RL
    • et al.

    Association of mindfulness-based interventions with anxiety severity in adults with cancer: a systematic review and meta-analysis.

    JAMA Netw Open. 2020; 3e2012598

  • 40.
    • Sun H
    • Huang H
    • Ji S
    • et al.

    The efficacy of cognitive behavioral therapy to treat depression and anxiety and improve quality of life among early-stage breast cancer patients.

    Integr Cancer Ther. 2019; 18 ()

  • 41.
    • Mathew A
    • Doorenbos AZ
    • Jang MK
    • Hershberger PE

    Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model.

    J Cancer Surviv. 2021; 15: 427-451

  • 42.
    • National Comprehensive Cancer Network

    NCCN guidelines: survivorship.

  • 43.
    • Andersen BL
    • DeRubeis RJ
    • Berman BS
    • et al.

    Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation.

    J Clin Oncol. 2014; 32: 1605-1619

  • 44.
    • Ostuzzi G
    • Matcham F
    • Dauchy S
    • Barbui C
    • Hotopf M

    Antidepressants for the treatment of depression in people with cancer.

    Cochrane Database Syst Rev. 2018; 4CD011006

  • 45.
    • Simard S
    • Thewes B
    • Humphris G
    • et al.

    Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies.

    J Cancer Surviv. 2013; 7: 300-322

  • 46.
    • Tauber NM
    • O’Toole MS
    • Dinkel A
    • et al.

    Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis.

    J Clin Oncol. 2019; 37: 2899-2915

  • 47.
    • Butow PN
    • Turner J
    • Gilchrist J
    • et al.

    Randomized trial of Conquerfear: a novel, theoretically based psychosocial intervention for fear of cancer recurrence.

    J Clin Oncol. 2017; 35: 4066-4077

  • 48.
    • Janelsins MC
    • Kesler SR
    • Ahles TA
    • Morrow GR

    Prevalence, mechanisms, and management of cancer-related cognitive impairment.

    Int Rev Psychiatry. 2014; 26: 102-113

  • 49.
    • Mayo SJ
    • Lustberg M
    • Dhillon HM
    • et al.

    Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group.

    Support Care Cancer. 2020; 29: 2821-2840

  • 50.
    • Fernandes HA
    • Richard NM
    • Edelstein K

    Cognitive rehabilitation for cancer-related cognitive dysfunction: a systematic review.

    Support Care Cancer. 2019; 27: 3253-3279

  • 51.
    • Campbell KL
    • Zadravec K
    • Bland KA
    • Chesley E
    • Wolf F
    • Janelsins MC

    The effect of exercise on cancer-related cognitive impairment and applications for physical therapy: systematic review of randomized controlled trials.

    Phys Ther. 2020; 100: 523-542

  • 52.
    • Al Maqbali M
    • Al Sinani M
    • Al Naamani Z
    • Al Badi K
    • Tanash MI

    Prevalence of fatigue in patients with cancer: a systematic review and meta-analysis.

    J Pain Symptom Manage. 2021; 61: 167-189.e14

  • 53.
    • Bower JE
    • Ganz PA
    • Desmond KA
    • et al.

    Fatigue in long-term breast carcinoma survivors: a longitudinal investigation.

    Cancer. 2006; 106: 751-758

  • 54.
    • Kessels E
    • Husson O
    • van der Feltz-Cornelis CM

    The effect of exercise on cancer-related fatigue in cancer survivors: a systematic review and meta-analysis.

    Neuropsychiatr Dis Treat. 2018; 14: 479-494

  • 55.
    • Corbett TK
    • Groarke A
    • Devane D
    • Carr E
    • Walsh JC
    • McGuire BE

    The effectiveness of psychological interventions for fatigue in cancer survivors: systematic review of randomised controlled trials.

    Syst Rev. 2019; 8: 324

  • 56.
    • Howell D
    • Oliver TK
    • Keller-Olaman S
    • et al.

    Sleep disturbance in adults with cancer: a systematic review of evidence for best practices in assessment and management for clinical practice.

    Ann Oncol. 2014; 25: 791-800

  • 57.
    • Jefford M
    • Ward AC
    • Lisy K
    • et al.

    Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study.

    Support Care Cancer. 2017; 25: 3171-3179

  • 58.
    • Johnson JA
    • Rash JA
    • Campbell TS
    • et al.

    A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors.

    Sleep Med Rev. 2016; 27: 20-28

  • 59.
    • Carter J
    • Lacchetti C
    • Andersen BL
    • et al.

    Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline.

    J Clin Oncol. 2018; 36: 492-511

  • 60.
    • Carter J
    • Stabile C
    • Seidel B
    • Baser RE
    • Goldfarb S
    • Goldfrank DJ

    Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors.

    J Cancer Surviv. 2017; 11: 274-283

  • 61.
    • Hersch J
    • Juraskova I
    • Price M
    • Mullan B

    Psychosocial interventions and quality of life in gynaecological cancer patients: a systematic review.

    Psychooncology. 2009; 18: 795-810

  • 62.
    • Tamminga SJ
    • de Boer AG
    • Verbeek JH
    • Frings-Dresen MH

    Return-to-work interventions integrated into cancer care: a systematic review.

    Occup Environ Med. 2010; 67: 639-648

  • 63.
    • de Boer AEG
    • Taskila TK
    • Tamminga SJ
    • Feuerstein M
    • Frings-Dresen MH
    • Verbeek JH

    Interventions to enhance return-to-work for cancer patients.

    Cochrane Database Syst Rev. 2015; 2017CD007569

  • 64.
    • Gordon LG
    • Merollini KMD
    • Lowe A
    • Chan RJ

    A systematic review of financial toxicity among cancer survivors: we can’t pay the co-pay.

    Patient. 2017; 10: 295-309

  • 65.
    • Hill RE
    • Wakefield CE
    • Cohn RJ
    • et al.

    Survivorship care plans in cancer: a meta-analysis and systematic review of care plan outcomes.

    Oncologist. 2020; 25: e351-e372

  • 66.
    • National Comprehensive Cancer Network

    NCCN clinical practice guidelines in oncology: distress management.

  • 67.
    • Sung H
    • Hyun N
    • Leach CR
    • Yabroff KR
    • Jemal A

    Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in the United States.

    JAMA. 2020; 324: 2521-2535

  • 68.
    • Perez DG
    • Loprinzi C
    • Ruddy KJ

    Lifestyle factors can lead to multiple cancers over a lifetime—here we go again.

    JAMA Oncol. 2021; 7: 505-506

  • 69.
    • American Society of Clinical Oncology

    Obesity and cancer: a guide for oncology providers.

  • 70.
    • Blanchard CM
    • Courneya KS
    • Stein K

    Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II.

    J Clin Oncol. 2008; 26: 2198-2204

  • 71.
    • Friedenreich CM
    • Stone CR
    • Cheung WY
    • Hayes SC

    Physical activity and mortality in cancer survivors: a systematic review and meta-analysis.

    JNCI Cancer Spectr. 2019; 4pkz080

  • 72.
    • Schmitz KH
    • Campbell AM
    • Stuiver MM
    • et al.

    Exercise is medicine in oncology: engaging clinicians to help patients move through cancer.

    CA Cancer J Clin. 2019; 69: 468-484

  • 73.
    • American Society of Clinical Oncology

    Tobacco cessation guide for oncology providers.

  • 74.
    • National Comprehensive Cancer Network

    NCCN clinical practice guidelines in oncology: smoking cessation.

  • 75.
    • Bagnardi V
    • Rota M
    • Botteri E
    • et al.

    Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis.

    Br J Cancer. 2015; 112: 580-593

  • 76.
    • LoConte NK
    • Brewster AM
    • Kaur JS
    • Merrill JK
    • Alberg AJ

    Alcohol and cancer: a statement of the American Society of Clinical Oncology.

    J Clin Oncol. 2018; 36: 83-93

  • 77.
    • National Comprehensive Cancer Network

    NCCN clinical practice guidelines in oncology: breast cancer.

  • 78.
    • Runowicz CD
    • Leach CR
    • Henry NL
    • et al.

    American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.

    J Clin Oncol. 2016; 34: 611-635

  • 79.
    • National Institute for Health and Care Excellence

    Early and locally advanced breast cancer: diagnosis and management.

  • 80.
    • Cardoso F
    • Kyriakides S
    • Ohno S
    • et al.

    Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

    Ann Oncol. 2019; 30: 1194-1220

  • 81.
    • Meyerhardt JA
    • Mangu PB
    • Flynn PJ
    • et al.

    Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement.

    J Clin Oncol. 2013; 31: 4465-4470

  • 82.
    • National Institute for Health and Care Excellence

    Colorectal cancer: 1.6 Ongoing care and support.

  • 83.
    • Argiles G
    • Tabernero J
    • Labianca R
    • et al.

    Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

    Ann Oncol. 2020; 31: 1291-1305

  • 84.
    • Resnick MJ
    • Lacchetti C
    • Bergman J
    • et al.

    Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement.

    J Clin Oncol. 2015; 33: 1078-1085

  • 85.
    • National Institute for Health and Care Excellence

    Prostate cancer: diagnosis and management.

  • 86.
    • Van den Broeck T
    • Cumberbatch M
    • Farolfi A
    • et al.

    Prostate cancer: 7. Follow-up.

  • 87.
    • National Institute for Health and Care Excellence

    Melanoma: assessment and management.

  • 88.

    Clinical practice guidelines for the diagnosis and management of melanoma.

  • 89.
    • Spetz J
    • Moslehi J
    • Sarosiek K

    Radiation-induced cardiovascular toxicity: mechanisms, prevention, and treatment.

    Curr Treat Options Cardiovasc Med. 2018; 20: 31

  • 90.
    • Westerink NL
    • Nuver J
    • Lefrandt JD
    • Vrieling AH
    • Gietema JA
    • Walenkamp AME

    Cancer treatment induced metabolic syndrome: improving outcome with lifestyle.

    Crit Rev Oncol Hematol. 2016; 108: 128-136

  • 91.
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults

    Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III).

    JAMA. 2001; 285: 2486-2497

  • 92.
    • Ferguson CM
    • Swaroop MN
    • Horick N
    • et al.

    Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer.

    J Clin Oncol. 2016; 34: 691-698

  • 93.
    • Kwan ML
    • Cohn JC
    • Armer JM
    • Stewart BR
    • Cormier JN

    Exercise in patients with lymphedema: a systematic review of the contemporary literature.

    J Cancer Surviv. 2011; 5: 320-336

  • 94.
    • National Comprehensive Cancer Network

    NCCN clinical practice guidelines in oncology: adult cancer pain.

  • 95.

    Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review.

    Palliat Med. 2011; 25: 553-559

  • 96.

    Bone loss and fracture risk associated with cancer therapy.

    Oncologist. 2006; 11: 1121-1131

  • 97.
    • Tai V
    • Leung W
    • Grey A
    • Reid IR
    • Bolland MJ

    Calcium intake and bone mineral density: systematic review and meta-analysis.

    BMJ. 2015; 351h4183

  • 98.
    • Postow MA
    • Sidlow R
    • Hellmann MD

    Immune-related adverse events associated with immune checkpoint blockade.

    N Engl J Med. 2018; 378: 158-168

  • 99.

    Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis.

    J Natl Compr Canc Netw. 2010; 8: 487-494

  • 100.

    A meta-analysis of the efficacy of cognitive behavior therapy on quality of life and psychological health of breast cancer survivors and patients.

    Psychooncology. 2018; 27: 1695-1703

  • 101.
    • Rudy L
    • Maheu C
    • Körner A
    • Lebel S
    • Gélinas C

    The FCR-1: initial validation of a single-item measure of fear of cancer recurrence.

    Psychooncology. 2020; 29: 788-795

  • 102.

    Systematic review of interventions by non-mental health specialists for managing fear of cancer recurrence in adult cancer survivors.

    Support Care Cancer. 2019; 27: 4055-4067

  • 103.
    • Von Ah D
    • Storey S
    • Tallman E
    • Nielsen A
    • Johns SA
    • Pressler S

    Cancer, cognitive impairment, and work-related outcomes: an integrative review.

    Oncol Nurs Forum. 2016; 43: 602-616

  • 104.
    • Karschnia P
    • Parsons MW
    • Dietrich J

    Pharmacologic management of cognitive impairment induced by cancer therapy.

    Lancet Oncol. 2019; 20: e92-102

  • 105.
    • Bower JE
    • Bak K
    • Berger A
    • et al.

    Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation.

    J Clin Oncol. 2014; 32: 1840-1850

  • 106.
    • Curt GA
    • Breitbart W
    • Cella D
    • et al.

    Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition.

    Oncologist. 2000; 5: 353-360

  • 107.
    • Sateia MJ
    • Buysse DJ
    • Krystal AD
    • Neubauer DN
    • Heald JL

    Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine Clinical Practice Guideline.

    J Clin Sleep Med. 2017; 13: 307-349

  • 108.
    • Parry C
    • Kent EE
    • Mariotto AB
    • Alfano CM
    • Rowland JH

    Cancer survivors: a booming population.

    Cancer Epidemiol Biomarkers Prev. 2011; 20: 1996-2005

  • 109.
    • Butow P
    • Laidsaar-Powell R
    • Konings S
    • Lim CYS
    • Koczwara B

    Return to work after a cancer diagnosis: a meta-review of reviews and a meta-synthesis of recent qualitative studies.

    J Cancer Surviv. 2020; 14: 114-134

  • 110.

    Financial distress in cancer patients.

    J Med Person. 2013; 11: 73-77

  • 111.
    • Sarfati D
    • Koczwara B
    • Jackson C

    The impact of comorbidity on cancer and its treatment.

    CA Cancer J Clin. 2016; 66: 337-350

  • 112.
    • Turner JP
    • Kantilal K
    • Kantilal K
    • Holmes HM
    • Koczwara B

    Optimising medications for patients with cancer and multimorbidity: the case for deprescribing.

    Clin Oncol (R Coll Radiol). 2020; 32: 609-617

  • 113.
    • Rowland JH
    • Gallicchio L
    • Mollica M
    • Saiontz N
    • Falisi AL
    • Tesauro G

    Survivorship science at the NIH: lessons learned from grants funded in fiscal year 2016.

    J Natl Cancer Inst. 2019; 111: 109-117

    About the author

    steps2world

    Leave a Comment